EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of MicroRNAs in Aortic Stenosis—Lessons from Recent Clinical Research Studies

Anna Krauze, Grzegorz Procyk iD, Aleksandra Gąsecka iD, Izabela Garstka-Pacak, Małgorzata Wrzosek iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241713095 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anna Krauze und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Pharmacogenomics, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland. Hauptthemen laut MEDLINE: MicroRNAs, Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aortic stenosis (AS) is the most prevalent primary valve lesion demanding intervention. Two main treatment options are surgical aortic valve replacement or transcatheter aortic valve implantation. There is an unmet need for biomarkers that could predict treatment outcomes and become a helpful tool in guiding Heart Team in the decision-making process. Micro-ribonucleic acids (microRNAs/miRs) have emerged as potential biomarkers thoroughly studied in recent years. In this review, we aimed to summarize the current knowledge about the role of miRNAs in AS based on human subject research. Much research investigating miRNAs’ role in AS has been conducted so far. We included 32 original human subject research relevant to the discussed field. Most of the presented miRNAs were studied only by a single research group. Nevertheless, several miRNAs appeared more than once, sometimes with high consistency between different studies but sometimes with apparent discrepancies. The molecular aspects of diseases are doubtlessly exciting and provide invaluable insights into the pathophysiology. Nevertheless, translating these findings, regarding biomarkers such as miRNAs, into clinical practice requires much effort, time, and further research with a focus on validating existing evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAortic Valve StenosisTranscatheter Aortic Valve ReplacementHumansHeartCatheters

Stichwörter der Autor:innen

aortic stenosisaortic valve replacementbiomarkerscalcific aortic valve diseasemicroRNAs

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Department of Biochemistry and Pharmacogenomics, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.
  • 1st Chair and Department of Cardiology, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.
  • Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland.

ORCID-Profile: Grzegorz Procyk, Aleksandra Gąsecka, Małgorzata Wrzosek

Zitieren

APA

Krauze, A., Procyk, G., Gąsecka, A., Garstka-Pacak, I., & Wrzosek, M. (2023). The Role of MicroRNAs in Aortic Stenosis—Lessons from Recent Clinical Research Studies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713095

Vancouver

Krauze A, Procyk G, Gąsecka A, Garstka-Pacak I, Wrzosek M. The Role of MicroRNAs in Aortic Stenosis—Lessons from Recent Clinical Research Studies. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713095

BibTeX
@article{Krauze2023,
  author = {Krauze, Anna and Procyk, Grzegorz and Gąsecka, Aleksandra and Garstka-Pacak, Izabela and Wrzosek, Małgorzata},
  title = {The Role of MicroRNAs in Aortic Stenosis—Lessons from Recent Clinical Research Studies},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241713095}
}
Kostenlos starten →